The resulting fluctuations in PTH levels ultimately reflects the antagonistic effect of tumor-induced hypercalcemia, which intermittently suppresses PTH secretion through negative feedback, producing a cyclical pattern. This evidence concerns the gene PTH and hypercalcemia disease.